Asset Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Sell
2,351
-53
-2% -$7.42K 0.05% 120
2025
Q4
$295K Buy
2,404
+13
+0.5% +$1.58K 0.05% 125
2025
Q3
$265K Buy
2,391
+15
+0.6% +$1.71K 0.04% 124
2025
Q2
$263K Sell
2,376
-138
-5% -$14.7K 0.05% 123
2025
Q1
$282K Buy
2,514
+17
+0.7% +$1.75K 0.05% 120
2024
Q4
$231K Buy
2,497
+13
+0.5% +$1.17K 0.04% 127
2024
Q3
$208K Buy
+2,484
New +$190K 0.04% 133
2023
Q3
Sell
-2,999
Closed -$231K 127
2023
Q2
$231K Buy
2,999
+29
+1% +$2.31K 0.05% 120
2023
Q1
$246K Buy
2,970
+27
+0.9% +$2.24K 0.06% 114
2022
Q4
$253K Buy
+2,943
New +$233K 0.06% 112
2022
Q3
Sell
-3,492
Closed -$216K 119
2022
Q2
$216K Buy
3,492
+34
+1% +$2.1K 0.05% 118
2022
Q1
$206K Buy
3,458
+42
+1% +$2.69K 0.04% 121
2021
Q4
$248K Buy
3,416
+33
+1% +$2.27K 0.05% 117
2021
Q3
$236K Buy
3,383
+29
+0.9% +$2.04K 0.05% 120
2021
Q2
$231K Buy
3,354
+33
+1% +$2.2K 0.05% 123
2021
Q1
$215K Buy
+3,321
New +$214K 0.05% 120
2020
Q4
Sell
-9,368
Closed -$592K 120
2020
Q3
$592K Buy
9,368
+309
+3% +$21.4K 0.17% 85
2020
Q2
$697K Buy
9,059
+282
+3% +$21.6K 0.22% 78
2020
Q1
$656K Buy
+8,777
New +$606K 0.25% 75

Other funds holding GILD

Asset Management Group's GILD Position: Q1 2026 in Review

Asset Management Group reduced its Gilead Sciences (GILD) stake by 2.2% in Q1 2026, selling an estimated $7.42K and leaving 2,351 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #120.

Asset Management Group first reported a position in GILD in Q1 2020 and has held it in 19 quarters since. The position peaked at $697K in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Asset Management Group held 2,351 shares of Gilead Sciences worth $328K as of Q1 2026.
  • Asset Management Group sold 53 Gilead Sciences shares in Q1 2026, an estimated $7.42K.
  • Gilead Sciences made up 0.05% of Asset Management Group's portfolio in Q1 2026, its #120 holding.
  • Asset Management Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 19 quarters since.
  • Asset Management Group's Gilead Sciences position peaked at $697K in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Asset Management Group's 13F filing for Q1 2026, filed 15 May 2026.